Belinsky S A, Foley J F, White C M, Anderson M W, Maronpot R R
Laboratory of Molecular Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709.
Cancer Res. 1990 Jun 15;50(12):3772-80.
The relationship between the formation of O6-methylguanine (O6MG) and the induction of lung, liver, and nasal tumors in the Fisher 344 rat by the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) was examined in a dose-response study. Animals were treated for 20 wk (3 times/wk) with concentrations of NNK ranging from 0.03 to 50 mg/kg to induce tumors. Steady-state concentrations of O6MG were quantitated, and cytotoxicity was assessed in target cells and tissues after 4 wk of treatment with NNK. No cytotoxicity was detected in the lung during treatment with NNK. The formation of O6MG was greatest in Clara cells compared with macrophages, type II cells, small cells, and whole lung at all doses examined. The difference in adduct concentration between the Clara cell and other pulmonary cell types was most pronounced with low doses of carcinogen. The O6MG:dose ratio, an index of alkylation efficiency, increased 29-fold as the dose of NNK was decreased from 50 to 1 mg/kg of carcinogen. In contrast, only a small increase in alkylation efficiency was observed in type II cells and whole lung. A significant number of tumors were induced in the lung at doses of 0.1 to 50 mg/kg with incidences ranging from 10% at the lowest dose up to 87% in the group of animals which received 50 mg/kg of NNK. A linear relationship was observed when the concentration of O6MG in Clara cells as a function of dose was plotted against the corresponding tumor incidence. This relationship was not observed using DNA adduct concentrations in type II cells or whole lung. The development of pulmonary tumors appeared to involve the formation of alveolar hyperplasias which progressed to adenomas and finally to carcinomas. The majority of adenomas were solid, whereas carcinomas were mainly papillary. Examination of the ultrastructure of the hyperplasias, adenomas, and carcinomas revealed morphological structures (e.g., lamellar bodies, tubular myelin) which are associated with type II cells. Thus, these data suggest that the majority of neoplasms in the lung begin as type II cell proliferations with progression to adenomas and carcinomas within the areas of hyperplasia. The lack of agreement between biochemical and morphological findings makes it difficult to hypothesize a cell of origin for the pulmonary neoplasms. In contrast to the lung, tumors were induced in the liver and nasal passages only after exposure to high doses of NNK. Moreover, both the formation of DNA adducts and cytotoxicity appear obligatory for the generation of tumors in these tissues.(ABSTRACT TRUNCATED AT 400 WORDS)
在一项剂量反应研究中,检测了烟草特异性亚硝胺4-(甲基亚硝胺基)-1-(3-吡啶基)-1-丁酮(NNK)诱导的O6-甲基鸟嘌呤(O6MG)形成与Fisher 344大鼠肺、肝和鼻肿瘤发生之间的关系。用浓度范围为0.03至50mg/kg的NNK对动物进行20周治疗(每周3次)以诱导肿瘤。对O6MG的稳态浓度进行定量,并在NNK治疗4周后评估靶细胞和组织中的细胞毒性。在NNK治疗期间,未在肺中检测到细胞毒性。在所有检测剂量下,与巨噬细胞、II型细胞、小细胞和全肺相比,Clara细胞中O6MG的形成最多。低剂量致癌物时,Clara细胞与其他肺细胞类型之间的加合物浓度差异最为明显。随着NNK剂量从50mg/kg降至1mg/kg致癌物,O6MG:剂量比(烷基化效率指标)增加了29倍。相比之下,II型细胞和全肺中仅观察到烷基化效率有小幅增加。在0.1至50mg/kg剂量下,肺中诱导出大量肿瘤,发病率从最低剂量的10%到接受50mg/kg NNK的动物组中的87%不等。当将Clara细胞中O6MG浓度作为剂量的函数与相应的肿瘤发病率作图时,观察到线性关系。使用II型细胞或全肺中的DNA加合物浓度未观察到这种关系。肺肿瘤的发生似乎涉及肺泡增生的形成,其发展为腺瘤,最终发展为癌。大多数腺瘤为实性,而癌主要为乳头状。对增生、腺瘤和癌的超微结构检查揭示了与II型细胞相关的形态结构(如板层小体、管状髓磷脂)。因此,这些数据表明,肺中的大多数肿瘤始于II型细胞增殖,并在增生区域内发展为腺瘤和癌。生化和形态学结果之间缺乏一致性,使得难以推测肺肿瘤的起源细胞。与肺相反,仅在暴露于高剂量NNK后,肝和鼻道中才诱导出肿瘤。此外,DNA加合物的形成和细胞毒性似乎都是这些组织中肿瘤发生所必需的。(摘要截断于400字)